Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus
van Vollenhoven, R. F., B. H. Hahn, G. C. Tsokos, P. Lipsky, K. Fei, R. M. Gordon, I. Gregan, K. H. Lo, M. Chevrier, and S. Rose. 2020. “Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus”. Arthritis Rheumatol 72: 761-68.